These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37435880)

  • 1. Anticoagulation against portal vein thrombosis reduces mortality and liver cirrhosis-related complications: A propensity score-matched study.
    Sato A; Watanabe S; Iseki M; Yamada Y; Kobayashi R; Furuya M; Arai K; Ohshina E; Tashiro Y; Nozaka T; Matsuoka M; Yauchi M; Kobayashi K; Matsumoto T; Furumoto Y; Asano T; Azuma S
    Hepatol Res; 2023 Nov; 53(11):1096-1104. PubMed ID: 37435880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study.
    Shi Y; Feng W; Cai J; Wang Z; Pu Y; Mao W; Zhan K; Chen D
    BMC Gastroenterol; 2024 Jul; 24(1):224. PubMed ID: 39003447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for Non-tumoral Cirrhotic Portal Vein Thrombosis Not Responding to Anticoagulation Therapy.
    Mukund A; Marri UK; Jindal A; Choudhury A; Patidar Y; Sarin SK
    Dig Dis Sci; 2023 Jul; 68(7):3174-3184. PubMed ID: 37169934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
    Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
    Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
    Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.
    Gao Z; Li S; Zhao J; Li J; Gao Y
    Intern Emerg Med; 2023 Mar; 18(2):513-521. PubMed ID: 36692588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
    Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Lv Y; Bai W; Li K; Wang Z; Guo W; Luo B; Wang J; Wang Q; Wang E; Xia D; Li X; Yuan J; Han N; Niu J; Yin Z; Fan D; Han G
    Am J Gastroenterol; 2021 Jul; 116(7):1447-1464. PubMed ID: 33630766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transjugular intrahepatic portosystemic with endoscopic treatment plus anticoagulation for esophageal variceal bleeding and portal vein thrombosis in liver cirrhosis.
    Wu W; Zhang H; Zeng Z; Wang X; Kong D
    Scand J Gastroenterol; 2022 Dec; 57(12):1494-1502. PubMed ID: 35802771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of portal vein thrombosis on the prognosis and liver function of nonmalignant cirrhotic patients.
    Endo K; Oikawa T; Kakisaka K; Tamura A; Ehara S; Takikawa Y
    Scand J Gastroenterol; 2018; 53(10-11):1340-1346. PubMed ID: 30257110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients.
    Benevento F; Pecorelli A; Stefanescu H; Sparchez Z; Vukotic R; Pettinari I; Grigoras CA; Tovoli F; Ravaioli F; Stefanini B; Andreone P; Piscaglia F
    J Hepatocell Carcinoma; 2023; 10():473-482. PubMed ID: 37007210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat?
    Dong S; Qi H; Li Y; Men P; Alifu M; Zhang Y; Li Y; Zhao R
    Hepatol Int; 2021 Dec; 15(6):1356-1375. PubMed ID: 34487316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis.
    Rugivarodom M; Charatcharoenwitthaya P
    J Clin Transl Hepatol; 2020 Dec; 8(4):432-444. PubMed ID: 33447527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of warfarin in cirrhotic patients with non-symptomatic portal vein thrombosis: a multicenter, randomized controlled trial.
    Lu S; Chen J; Zhang R; Luo T; Ma L; Xu P; Ding H; Zeng X; Wu B; Shi Y; Liu C; Mu Y; Chen S; Wang J
    Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):5-12. PubMed ID: 38236640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Non-Tumoral Portal Vein Thrombosis Management in Cirrhotic Patients: TIPS Versus Anticoagulation Versus No Treatment.
    Zhan C; Prabhu V; Kang SK; Li C; Zhu Y; Kim S; Olsen S; Jacobson IM; Dagher NN; Carney B; Hickey RM; Taslakian B
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34073236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
    Hayashi T; Takatori H; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Kitamura K; Kawaguchi K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Toyama T; Okumura K; Kozaka K; Kaneko S
    BMC Gastroenterol; 2019 Dec; 19(1):217. PubMed ID: 31842768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.